FDA’s Elizabeth H. Dickinson Tapped to Serve as Acting Chief Counsel

FDA Law Blog has learned that Elizabeth H. Dickinson, who currently serves as Associate Chief Counsel for Drugs in FDA’s Office of Chief Counsel, will serve as FDA’s Acting Chief Counsel effective on August 7th.  As we previously reported, FDA’s current Chief Counsel, Ralph Tyler, recently gave word that he will be leaving FDA effective as of August 5th.  Ms. Dickinson is very well known to the Food and Drug Bar, and in particular among the Hatch-Waxman community.  Ms. Dickinson received her B.A. in Economics from the University of Massachusetts, and her J.D. from Northeastern University.  She was law clerk to the Honorable William B. Bryant of the U.S. District Court for the District of Columbia, and has been with FDA since 1994.  Ms. Dickinson was awarded the Food and Drug Law Institute’s Distinguished Service and Leadership Award in 2009, the National Organization for Rare Disorders’ Public Health Leadership Award in 2005, and has received several FDA and Department awards for legal services.